Harry F. Hixson, Jr.

2013

In 2013, Harry F. Hixson, Jr. earned a total compensation of $214K as Interim Chief Executive Officer and Director at Arena Pharmaceuticals.

Compensation breakdown

Stock Awards$164,994
Other$49,000
Total$213,994

Hixson received $165K in stock awards, accounting for 77% of the total pay in 2013.

Hixson also received $49K in other compensation.

Rankings

In 2013, Harry F. Hixson, Jr.'s compensation ranked 11,497th out of 12,286 executives tracked by ExecPay. In other words, Hixson earned more than 6.4% of executives.

ClassificationRankingPercentile
All
11,497
out of 12,286
6th
Division
Manufacturing
4,316
out of 4,612
6th
Major group
Chemicals And Allied Products
1,366
out of 1,462
7th
Industry group
Drugs
1,084
out of 1,156
6th
Industry
Pharmaceutical Preparations
840
out of 890
6th
Source: SEC filing on April 28, 2016.

Hixson's colleagues

We found five more compensation records of executives who worked with Harry F. Hixson, Jr. at Arena Pharmaceuticals in 2013.

2013

Jack Lief

Arena Pharmaceuticals

Chief Executive Officer

2013

Dominic Behan

Arena Pharmaceuticals

Chief Scientific Officer

2013

Steven Spector

Arena Pharmaceuticals

General Counsel

2013

William Shanahan

Arena Pharmaceuticals

Chief Medical Officer

2013

Robert Hoffman

Arena Pharmaceuticals

Chief Financial Officer

You may also like